Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 291

1.

Defining the timing of action of antimalarial drugs against Plasmodium falciparum.

Wilson DW, Langer C, Goodman CD, McFadden GI, Beeson JG.

Antimicrob Agents Chemother. 2013 Mar;57(3):1455-67. doi: 10.1128/AAC.01881-12. Epub 2013 Jan 14.

2.

Screening and evaluation of inhibitors of Plasmodium falciparum merozoite egress and invasion using cytometry.

Bouillon A, Gorgette O, Mercereau-Puijalon O, Barale JC.

Methods Mol Biol. 2013;923:523-34.

PMID:
22990802
3.

In vitro and in vivo properties of ellagic acid in malaria treatment.

Soh PN, Witkowski B, Olagnier D, Nicolau ML, Garcia-Alvarez MC, Berry A, Benoit-Vical F.

Antimicrob Agents Chemother. 2009 Mar;53(3):1100-6. doi: 10.1128/AAC.01175-08. Epub 2008 Nov 17.

4.

Digestion of the host erythrocyte by malaria parasites is the primary target for quinoline-containing antimalarials.

Zarchin S, Krugliak M, Ginsburg H.

Biochem Pharmacol. 1986 Jul 15;35(14):2435-42.

PMID:
3524576
5.

In vitro sensitivity of Plasmodium falciparum to conventional and novel antimalarial drugs in Papua New Guinea.

Wong RP, Lautu D, Tavul L, Hackett SL, Siba P, Karunajeewa HA, Ilett KF, Mueller I, Davis TM.

Trop Med Int Health. 2010 Mar;15(3):342-9. doi: 10.1111/j.1365-3156.2009.02463.x. Epub 2010 Jan 11.

6.

[In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].

Touré AO, Koné LP, Jambou R, Konan TD, Demba S, Beugre GE, Koné M.

Sante. 2008 Jan-Mar;18(1):43-7. doi: 10.1684/san.2008.0103. French.

8.

In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs.

Skinner TS, Manning LS, Johnston WA, Davis TM.

Int J Parasitol. 1996 May;26(5):519-25.

PMID:
8818732
9.

Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007.

Lim P, Wongsrichanalai C, Chim P, Khim N, Kim S, Chy S, Sem R, Nhem S, Yi P, Duong S, Bouth DM, Genton B, Beck HP, Gobert JG, Rogers WO, Coppee JY, Fandeur T, Mercereau-Puijalon O, Ringwald P, Le Bras J, Ariey F.

Antimicrob Agents Chemother. 2010 May;54(5):2135-42. doi: 10.1128/AAC.01304-09. Epub 2010 Mar 1.

10.

Effects of dipyridamole on Plasmodium falciparum-infected erythrocytes.

Akaki M, Nakano Y, Ito Y, Nagayasu E, Aikawa M.

Parasitol Res. 2002 Dec;88(12):1044-50. Epub 2002 Aug 1.

PMID:
12444453
11.

Studies of resistance to chloroquine, quinine, amodiaquine and mefloquine among Philippine strains of Plasmodium falciparum.

Smrkovski LL, Buck RL, Alcantara AK, Rodriguez CS, Uylangco CV.

Trans R Soc Trop Med Hyg. 1985;79(1):37-41.

PMID:
3887681
12.

In vitro sensitivity pattern of chloroquine and artemisinin in Plasmodium falciparum.

Sharma S, Kaitholia K, Mishra N, Srivastava B, Pillai CR, Valecha N, Anvikar AR.

Indian J Med Microbiol. 2016 Oct-Dec;34(4):509-512. doi: 10.4103/0255-0857.195365.

13.

[In vitro activity of various antimalarials (chloroquine, amodiaquine, quinine and mefloquine) against 32 isolates of Plasmodium falciparum in French Guiana].

Dedet JP, Germanetto P, Cordoliani G, Bonnevie O, Le Bras J.

Bull Soc Pathol Exot Filiales. 1988;81(1):88-93. French.

PMID:
3042179
14.

Effects of combinations of quinoline-containing antimalarials on Plasmodium falciparum in culture.

Geary TG, Bonanni LC, Jensen JB, Ginsburg H.

Ann Trop Med Parasitol. 1986 Jun;80(3):285-91.

PMID:
3541805
15.

High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool.

Woodrow CJ, Dahlström S, Cooksey R, Flegg JA, Le Nagard H, Mentré F, Murillo C, Ménard D, Nosten F, Sriprawat K, Musset L, Quashie NB, Lim P, Fairhurst RM, Nsobya SL, Sinou V, Noedl H, Pradines B, Johnson JD, Guerin PJ, Sibley CH, Le Bras J.

Antimicrob Agents Chemother. 2013 Jul;57(7):3121-30. doi: 10.1128/AAC.02350-12. Epub 2013 Apr 22.

16.

Plasmodium falciparum: Solanum nudum SN-1 steroid antiplasmodial activity when combined with antimalarial drugs.

Pabón A, Deharo E, Blair S.

Exp Parasitol. 2011 Jan;127(1):222-7. doi: 10.1016/j.exppara.2010.08.009. Epub 2010 Aug 22.

PMID:
20736008
17.

In vitro and clinical correlates of mefloquine resistance of Plasmodium falciparum in eastern Thailand.

Childs GE, Bourdeau EF, Wimonwattratee T, Pang L, Milhous WK.

Am J Trop Med Hyg. 1991 May;44(5):553-9.

PMID:
2063958
18.

Indolone-N-oxide derivatives: in vitro activity against fresh clinical isolates of Plasmodium falciparum, stage specificity and in vitro interactions with established antimalarial drugs.

Tahar R, Vivas L, Basco L, Thompson E, Ibrahim H, Boyer J, Nepveu F.

J Antimicrob Chemother. 2011 Nov;66(11):2566-72. doi: 10.1093/jac/dkr320. Epub 2011 Aug 22.

PMID:
21862474
19.
20.

[Combined antimalarial therapy using artemisinin].

Majori G.

Parassitologia. 2004 Jun;46(1-2):85-7. Review. Italian.

PMID:
15305693

Supplemental Content

Support Center